KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Invested Capital (2016 - 2025)

AbbVie (ABBV) has disclosed Invested Capital for 14 consecutive years, with $61.8 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 12.35% to $61.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.8 billion through Dec 2025, down 12.35% year-over-year, with the annual reading at $61.8 billion for FY2025, 12.35% down from the prior year.
  • Invested Capital for Q4 2025 was $61.8 billion at AbbVie, up from -$660.0 million in the prior quarter.
  • The five-year high for Invested Capital was $92.1 billion in Q4 2021, with the low at -$660.0 million in Q3 2025.
  • Average Invested Capital over 5 years is $29.3 billion, with a median of $17.7 billion recorded in 2023.
  • The sharpest move saw Invested Capital skyrocketed 438.39% in 2021, then plummeted 108.18% in 2025.
  • Over 5 years, Invested Capital stood at $92.1 billion in 2021, then dropped by 12.54% to $80.6 billion in 2022, then fell by 13.38% to $69.8 billion in 2023, then increased by 0.98% to $70.5 billion in 2024, then fell by 12.35% to $61.8 billion in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $61.8 billion, -$660.0 million, and $1.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.